Peregrine Cancer Cure Technologies Private Limited
Founded in 2017 and headquartered in Karnataka, India.
2017 | Bangalore, Karnataka (India) | Inactive
Peregrine Cancer Cure Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -196.61%
- Ebitda -127.50%
- Net Worth -18.94%
- Total Assets -24.38%
About Peregrine Cancer Cure Technologies
Peregrine Cancer Cure Technologies Private Limited (PCCTPL) is Strike Off company established on 08 Sep 2017 with its office registered at Bangalore, Karnataka, India and has been running since 7 Year, 7 Months with a paid up capital of 1.00 M. According to MCA records, 2 Directors are linked to this company as of 02 Apr 2024.
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85200KA2017PTC106245
- Company No.
106245
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Veterinary
Peregrine Cancer Cure Technologies Private Limited
Explore comprehensive data for Peregrine Cancer Cure Technologies Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Peregrine Cancer Cure Technologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Soumya Rengarajan  | Director | 08-Sep-2017 | Current |
| Balachander Agoramurthy | Director | 08-Sep-2017 | Current |
Financial Performance of Peregrine Cancer Cure Technologies.
Peregrine Cancer Cure Technologies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 196.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Peregrine Cancer Cure Technologies?
Unlock access to Peregrine Cancer Cure Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Innov4sight Health And Biomedical Systems Private LimitedSoumya Rengarajan is a mutual person
- Brilliante Vista Private Limited
Balachander Agoramurthy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Peregrine Cancer Cure Technologies?
Unlock and access historical data on people associated with Peregrine Cancer Cure Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Peregrine Cancer Cure Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Peregrine Cancer Cure Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Peregrine Cancer Cure Technologies
Recent activity within the organization
- Annual General Meeting
Peregrine Cancer Cure Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
- Balance Sheet
Peregrine Cancer Cure Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore.
- Director Appointment
Soumya Rengarajan was appointed as a Director was appointed as a Director on 08 Sep 2017 & has been associated with this company since 7 years 7 months .
- Director Appointment
Balachander Agoramurthy was appointed as a Director was appointed as a Director on 08 Sep 2017 & has been associated with this company since 7 years 7 months .
- Company Incorporation
Peregrine Cancer Cure Technologies Private Limited was registered on 08 Sep 2017 with Roc Bangalore & aged 7 years 7 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Peregrine Cancer Cure Technologies Private Limited?
Peregrine Cancer Cure Technologies Private Limited was incorporated on 08 Sep 2017.
What is authorized share capital and paid-up capital of Peregrine Cancer Cure Technologies Private Limited?
The authorized share capital of Peregrine Cancer Cure Technologies Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Who are the current board members & directors of Peregrine Cancer Cure Technologies Private Limited?
Currently 2 directors are associated with Peregrine Cancer Cure Technologies Private Limited.
- Soumya Rengarajan
- Balachander Agoramurthy
What is the registered address of Peregrine Cancer Cure Technologies Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Peregrine Cancer Cure Technologies Private Limited is No.107 B Block Aban Essence 1St Floor, S.No.60 Kudlu Village Madiwala Post, Bangalore, Karnataka, India, 560068.
What is the corporate identification number (CIN) and company number of Peregrine Cancer Cure Technologies Private Limited?
The corporate identification number (CIN) of Peregrine Cancer Cure Technologies Private Limited is U85200KA2017PTC106245 and the company number is 106245 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Peregrine Cancer Cure Technologies Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Peregrine Cancer Cure Technologies Private Limited has experienced an downturn of -18.94%.
When was the last Balance Sheet of Peregrine Cancer Cure Technologies Private Limited filed with the ROC?
The most recent Balance Sheet for Peregrine Cancer Cure Technologies Private Limited was filed with the ROC on 31 Mar 2022.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records